Effect of drugs affecting synthesis or degradation of connexin on onset or completion of ethylene glycol induced inhibition of intercellular gap junctional communication

Neoplasma

Volumn 49, Issue 5, 2002, Pages 290-294

  Kralik P ^a   Vitek J A ^a  

^a Research Institute of Child Health Brno   (Czech Republic)

Author keywords

Connexin; Cycloheximide; DbcAMP; Ethylene glycol; Gap junctional communication; Protein synthesis

Indexed keywords

BUCLADESINE; CONNEXIN 43; CYCLOHEXIMIDE; DACTINOMYCIN; DYE; ETHYLENE GLYCOL; LEUPEPTIN; PROTEASOME; TUMOR PROMOTER;

ANIMAL CELL; ANTIBODY LABELING; ARTICLE; CELL COMMUNICATION; CELL FUNCTION; CELL MEMBRANE; CHO CELL; CONTROLLED STUDY; FEMALE; GAP JUNCTION; IMMUNOCYTOCHEMISTRY; NONHUMAN; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; TRANSCRIPTION TERMINATION; TRANSLATION REGULATION;

EID: 0036453556     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Asamoto M, Oyamada M, EL Aoumari A, Gros D, Yamasaki H. Molecular mechanisms of TPA-mediated inhibition of gap-junctional intercellular communication: Evidence for action on the assembly or function but not the expression of connexin 43 in rat liver epithelial cells. Molec Carcinog 1991; 4: 322-327.
2. Banoub RW, Fernstrom M, Malkinson AM, Ruch RJ. Enhancement of gap junctional intercellular communication by Dibutyryl cyclic AMP in lung epithelial cells. Anticancer Res 1996; 16: 3715-3720.
3. Budunova IV, Williams GM. Cell culture assays for chemicals with tumor-promoting activity based on the modulation of intercellular communication. Cell Biol Toxicol 1994; 10: 71-116.
4. Enomoto T, Martel N, Kanno Y, Yamasaki H. Inhibition of cell communication between Balb/C3T3 cells by tumor promoters and protection by cAMP. J Cell Physiol 1984; 121: 323-333.
5. Hertzberg EL, Johnson RG, editors. Gap junctions. In: Modern Cell Biology, vol. 7. New York: Alan R. Liss, Inc., 1988.
6. Kanno Y. Modulation of cell communication and carcinogenesis. Jap J Physiol 1985; 35: 693-707.
7. Laing JG, Beyer EC. The gap junction protein connexin43 is degraded via the ubiquitin-proteasome pathway. J Biol Chem 1995; 270: 26399-26403.
8. Laing JG, Tadros PN, Green K, Saffitz JE, Beyer EC. Proteolysis of connexin43-containing gap junctions in normal and heart-stressed cardiac myocytes. Cardiol Res 1998; 38: 711-718.
9. Laird DW, Casillo M, Kasprzak L. Gap junction turnover, intracellular trafficing, and phosphorylation of connexin43 in Brefeldin A-treated rat mammary tumor cells. J Cell Biol 1995; 131: 1193-1203.
10. Musil LS, Le A-CN, Van Slyke JK, Roberts LM. Regulation of connexin degradation as a mechanism to increase gap junction assembly and function. J Biol Chem 2000; 275: 25207-25215.
11. Peracchia C. Gap Junctions: Molecular Basis of Cell Communication in Health and Disease. Academic Press, London.
12. Traub O, Look J, Paul D, Willecke K. Cyclic adenosine monophoshate stimulates biosynthesis and phosphorylation of the 28 kDA gap junction protein in cultured mouse hepatocytes. Eur J Cell Biol 1987; 43: 48-54.
13. Vítek JA. Inhibition of intercellular gap junctional communication by alkyl ethers and its modulation by cAMP. Neoplasma 1993; 40: 167-172.
14. Vítek JA. The biological conditions of assessment of ethylene glycol communication by metabolic cooperation assay. Folia Biologica 1997; 43: 109-114.
15. Vítek JA. Selective gap junctional communication within the V79-4 Chinese hamster cell line. Folia Biologica 2001; 47: 163-170.
16. Vítek JA, Oborilová E, Mazura P, Benešová M. Renewal of a culture medium induces a temporary decrease in the gap junctional communication accompanied by degradation and re-establishment of gap junctions in the V79-4 Chinese hamster cell line. Folia Biologica 2002; 48: 108-113.